アンジオポエチン
文献・脚注

↑  PDB: 1Z3U​; Barton WA, Tzvetkova D, Nikolov DB (May 2005). “Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition”. Structure 13 (5):  825?32. doi:10.1016/j.str.2005.03.009. PMID 15893672.
1 2 3 4  Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (Dec 1996). “Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning”. Cell 87 (7):  1161-1169. PMID 8980223.
↑  Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (Dec 1996). “Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis”. Cell 87 (7):  1171-1180. doi:10.1016/S0092-8674(00)81813-9. PMID 8980224.
↑  Maisonpierre, P C; Suri C, Jones P F, Bartunkova S, Wiegand S J, Radziejewski C, Compton D, McClain J, Aldrich T H, Papadopoulos N, Daly T J, Davis S, Sato T N, Yancopoulos G D (Jul. 1997). “Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis”. Science (UNITED STATES) 277 (5322):  55-60. doi:10.1126/science.277.5322.55. ISSN 0036-8075. PMID 9204896.
↑  Rodewald HR, Sato TN (January 1996). “Tie1, a receptor tyrosine kinase essential for vascular endothelial cell integrity, is not critical for the development of hematopoietic cells”. Oncogene 12 (2):  397-404. PMID 8570217.
↑  Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M, Suda T (July 2000). “A role for hematopoietic stem cells in promoting angiogenesis”. Cell 102 (2):  199-209. doi:10.1016/S0092-8674(00)00025-8. PMID 10943840.
↑  Fagiani E, Christofori G (January 2013). “Angiopoietins in angiogenesis”. Cancer Letters 328 (1):  18-26. doi:10.1016/j.canlet.2012.08.018.
↑  Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM (Dec 1999). “Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1”. Science 286 (5449):  2511-2514. doi:10.1126/science.286.5449.2511.
↑  Amo Y, Masuzawa M, Hamada Y, Katsuoka K (May 2004). “Observations on angiopoietin 2 in patients with angiosarcoma”. Br. J. Dermatol. 150 (5):  1028-1029. doi:10.1111/j.1365-2133.2004.05932.x. PMID 15149523.
↑  Hauer AD, Habets KL, van Wanrooij EJ, et al. (October 2008). “Vaccination against TIE2 reduces atherosclerosis”. Atherosclerosis 204 (2):  365-371. doi:10.1016/j.atherosclerosis.2008.09.039. PMID 19022447.
↑  Hurliman AK, Speroff L, Stouffer RL, Patton PE, Lee A, Molskness TA (March 2010). “Changes in Circulating Levels and Ratios of Angiopoietins during Pregnancy, but not during the Menstrual Cycle and Controlled Ovarian Stimulation”. Fertil. Steril. 93 (5):  1493-1499. doi:10.1016/j.fertnstert.2009.04.036. PMC 2839053. PMID 19476937. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839053/.
↑  B Schreitmuller, T Leyhe, E Stransky, N Kohler, C Laske (2012). “Elevated Angiopoietin-1 Serum Levels in Patients with Alzheimer’s Disease”. International Journal of Alzheimer's Disease 2012:  1-5. doi:10.1155/2012/324016.
↑  Shroff RC, Price KL, Kolatsi-Joannou M, Todd AF, Wells D, Deanfield J, Johnson RJ, Rees L, Woolf AS, Long DA (Feb 2013). “Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis”. PLoS One 8 (2):  e56273. doi:10.1371/journal.pone.0056273. PMC 3568077. PMID 23409162. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568077/.
図１．アンジオポエチンのドメイン構造